LASCCO Announces Positive Scientific Advice Meeting with MHRA and Plans a First-In-Man Clinical Trial with CAL02 in Patients with Severe Pneumococcal Pneumonia GENEVA, SWITZERLAND, 22 October 2014 – LASCCO SA has held - Asplenia - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2014-10-23 10:01:03 Pneumonia Bacteria Microbiology Medicine Pneumococcal pneumonia Antimicrobial resistance Streptococcus pneumoniae Pneumococcal infection Bacterial pneumonia		LASCCO Announces Positive Scientific Advice Meeting with MHRA and Plans a First-In-Man Clinical Trial with CAL02 in Patients with Severe Pneumococcal Pneumonia GENEVA, SWITZERLAND, 22 October 2014 – LASCCO SA has held Add to Reading List Source URL: www.lascco.com Download Document from Source Website File Size: 57,93 KB Share Document on Facebook

	Meet Ryan Carpenter Ryan was born and raised in Moses Lake, WA. He grew up having family in Odessa, as his mother was a Zeiler. They had many visits growing up to see grandparents DocID: 1rmBY - View Document
	LASCCO Announces Positive Scientific Advice Meeting with MHRA and Plans a First-In-Man Clinical Trial with CAL02 in Patients with Severe Pneumococcal Pneumonia GENEVA, SWITZERLAND, 22 October 2014 – LASCCO SA has held DocID: 1rhtI - View Document
	HIN Logo_Color_Master_Standard Logo_CS2 DocID: 1qGRg - View Document
	Combioxin SA announces first patient enrolled in first-in-man study with CAL02 in patients with severe pneumococcal pneumonia 23 March 2016 GENEVA, SWITZERLAND – Combioxin SA announces that the first patient has been r DocID: 1qDYq - View Document
	ppsv - what you need to know- 508 compliant DocID: 1q1Yu - View Document